Stem Cell Therapy International, Inc., (PINKSHEETS: SCII) a company in the field of research and development of stem cell transplantation therapy and regenerative medicine, announced today that its CEO Calvin Cao and Igor Katkov, PhD., a member of the SCTI Medical and Scientific Advisory Board, have filed a provisional patent application at the U.S. Patent and Trademark Office to cover the composition and methods of treating severe burns with stem cells.
